Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center Prospective Study on PTX3 as a Predictor of Insulin Resistance and Inflammatory Resolution After Bariatric Surgery

NCT07241741 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

NCT NCT07241741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07241741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center Prospective Study on PTX3 as a Predictor of Insulin Resistance and Inflammatory Resolution After Bariatric Surgery
Lead sponsor
Istanbul University
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
September 1, 2025
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

c-reactive protein, chronic inflammation, inflammation, insulin resistance, interleukin-6, metabolic syndrome, obesity, roux en y gastric bypass